The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
about
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeInsulin-like growth factor-1 deficiency and metabolic syndromeDiagnosis and management of the metabolic syndrome in obesityFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewCilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbitsThe "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation?The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitusAdverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trialIncreasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general populationImpact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group.The metabolic syndromeAssociation of Metabolic Syndrome and C-reactive Protein Levels with Intracranial Atherosclerotic StrokeIncidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke StudyImpact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction.Metabolic syndrome in young Asian Indian patients with myocardial infarctionClinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort studyEffects of a community-based weight loss intervention on adipose tissue circulating factorsThe route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes.Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (CONFIRMAssociation of IL-6 polymorphism -174G/C and metabolic syndrome in hypertensive patients.Longitudinal and age trends of metabolic syndrome and its risk factors: the Family Heart Study.Improving physical activity and metabolic syndrome indicators in women: a transtheoretical model-based intervention.The role of triglycerides in atherosclerosis.Metabolic syndrome and risk for heart failure in middle-aged men.Four-Year Trends in Cardiometabolic Risk Factors according to Baseline Abdominal Obesity Status in West-African Adults: The Benin Study.Effects of a 12-month physical activity intervention on prevalence of metabolic syndrome in elderly men and women.New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003.K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome.Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?Prevention and treatment of the metabolic syndrome.Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey.Critical appraisal of revised cholesterol guidelines for the very high-risk patient.Circulatory syndrome: an evolution of the metabolic syndrome concept!Exercise training prevents diastolic dysfunction induced by metabolic syndrome in ratsDietary Fat Intake and the Risk of Metabolic Syndrome in Korean Adults.Metabolic syndrome does not improve the prediction of 5-year cardiovascular disease and total mortality over standard risk markers. Prospective population based study.Prevalence, Risk Factors, and Genetic Traits in Metabolically Healthy and Unhealthy Obese IndividualsEvaluation of heart rate reserve and high-sensitivity C-reactive protein in individuals with and without metabolic syndrome in Isfahan, Iran.Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome.
P2860
Q26752744-A2DD1609-46FD-4165-A108-DE8EBA0EC37FQ28072410-7A289D05-4F6F-483E-8E7E-ACE2D73BD555Q28192856-CA6CDC36-1564-4987-8F93-3478B4F230EAQ28220294-AB16E67D-5653-4C0B-B6F2-89E05F8BDA8AQ28728089-52F6C8B5-3304-421D-B91E-5D0871275D70Q30356827-3414640B-F2EE-4CF9-A832-F17C193AE865Q30357715-6AD08A85-3F04-4644-9450-8F04EA78B45DQ30379006-931ECE62-3583-4AB5-A4C0-4C111DD41EF0Q31114345-0DC7D602-D309-4038-862F-FC49509A792BQ33287044-A3075087-1B5C-48D6-8E97-8FEA00DE2B6CQ33435738-92379EEA-10ED-48BB-A53D-290E3E0F1876Q33569142-4BF51054-A6A1-4D4E-B99B-8DD259E9DB85Q33790692-F843CD7D-14F6-48E4-B8DA-98D223BD6826Q34038202-A6E37919-9FFD-4383-9C13-84002EAB8688Q34159728-BFBE1FA5-C642-42E0-8A78-016A8C4CB29BQ34220041-58EE1D56-E3A8-43D7-9137-DA50C1A90160Q34546527-7C842869-67A3-40CB-9E05-FE4098AA06EFQ34623147-A0704781-FDB6-4502-A1D0-EE8497879F98Q34642549-214DC3D8-4C2F-4D19-A411-60332B69E236Q35143798-9818D36F-B8F6-4E57-93E7-80875530F993Q35178007-6E50EBEA-C983-4096-A778-F9E449EBA19BQ35220001-6FC842C8-E963-4819-AFFD-55DA68C5DDFAQ35540575-502BC67B-63D0-402A-9FB1-73C2C1B4797FQ35602424-DDE2C51F-97E6-4EFB-813F-86BBCBCE5C24Q35772103-1B7A8321-F99A-4F31-927A-4830A02A5EB7Q35837971-65602D4B-2CED-4622-987B-82D703EF293BQ35845285-224C67D5-62C3-4830-BF7C-EAFC0BED899AQ35865512-89BC01BA-76A5-4FBF-B282-FB8F9BD34CFEQ35876408-FC82108C-F89F-4D26-A1B1-6E5F47B9F82CQ35881266-9D21200F-F327-4FD2-B289-216FA1B53A14Q35952447-77069EA0-F8F9-45D3-8F80-31F452B37CE9Q36049231-5F20C4C5-F2DA-42CD-9C7A-CE14377E5729Q36058567-4D6C6281-77A7-4A89-980A-0A647873FCDDQ36087928-07417709-6525-46A3-83B8-89B81695B571Q36104100-AC07D91A-CDAC-42DE-A4DF-EDBBEB87AE99Q36114227-D2C46318-0B22-4C3E-81B0-0B7F5A04A12DQ36152722-5BB1DB9D-DAEB-4DE6-A31C-BCE854F91814Q36172905-7CB0E3AE-F78C-44D3-9BE2-6D15A9F40674Q36296692-EE290B32-BF2E-42F0-ADD6-12D6EC47BD7AQ36329909-53B572EC-C836-443F-9339-64127361BB6F
P2860
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The metabolic syndrome and ris ...... ention Study (AFCAPS/TexCAPS).
@en
The metabolic syndrome and ris ...... ian Simvastatin Survival Study
@nl
type
label
The metabolic syndrome and ris ...... ention Study (AFCAPS/TexCAPS).
@en
The metabolic syndrome and ris ...... ian Simvastatin Survival Study
@nl
prefLabel
The metabolic syndrome and ris ...... ention Study (AFCAPS/TexCAPS).
@en
The metabolic syndrome and ris ...... ian Simvastatin Survival Study
@nl
P2093
P1476
The metabolic syndrome and ris ...... ention Study (AFCAPS/TexCAPS).
@en
P2093
4S Group and the AFCAPS/TexCAPS Research Group
Antonio M Gotto
Cynthia J Girman
Kalevi Pyörälä
Michael Clearfield
Michele Mercuri
Polly A Beere
Terje R Pedersen
Thomas Rhodes
P304
P356
10.1016/J.AMJCARD.2003.09.028
P407
P577
2004-01-01T00:00:00Z